300639 Guangdong Hybribio Biotech
- 5.37
- +0.10+1.90%
Guangdong Hybribio Biotech News
CapBio: Announcement on participating in the 2024 Investor Online Group Reception Day in Guangdong
Capbio: Announcement on the Company and Its Subsidiaries Obtaining Patent Authorization
Capbio: Investor Relations Activity Record Form for August 29, 2024
CapBio: CITIC Securities Co., Ltd.\'s verification opinion on the company\'s use of temporarily idle funds raised for cash management
Capbio: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Capbiotech: Announcement on the Use of Temporarily Idle Raised Funds for Cash Management
Capbio: Announcement of Board of Supervisory Committee Resolutions
Capbio: Announcement of Board Resolutions
Guangdong Hybribio Biotech: Stock trading has experienced abnormal fluctuations announcement.
Guangdong Hybribio Biotech: Announcement regarding the company and its subsidiaries being granted invention patent authorization.
Guangdong Hybribio Biotech: Announcement of Resolutions from the 20th Meeting of the 5th Board of Directors.
Guangdong Hybribio Biotech: Announcement of Resolutions of the Fifteenth Meeting of the Fifth Session of the Supervisory Board.
Guangdong Hybribio Biotech: Announcement of Resolution of the 14th Meeting of the Fifth Board of Supervisors.
Guangdong Hybribio Biotech: Announcement of the resolution of the 19th meeting of the 5th board of directors.
Guangdong Hybribio Biotech: Announcement Regarding Company and Its Subsidiaries Receiving Notice of Grant of Patent Rights
Guangdong Hybribio Biotech: Announcement Regarding Company and Its Subsidiaries Receiving Notice of Grant of Patent Rights
Guangdong Hybribio Biotech: May 9, 2024 Investor Relations Activity Schedule
Guangdong Hybribio Biotech: Announcement on holding the 2023 online results briefing
Guangdong Hybribio Biotech: Announcement of Resolutions of the 13th Meeting of the Fifth Board of Supervisors
Guangdong Hybribio Biotech: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Directors
Analysis
Price Target
No Data
